Conv. Plasma
Nigella Sativa
Peg.. Lambda

All vitamin D studies
Meta analysis
Home COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta
Cannabidiol Meta Molnupiravir Meta
Colchicine Meta
Conv. Plasma Meta
Curcumin Meta Nigella Sativa Meta
Ensovibep Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Peg.. Lambda Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Ivermectin Meta
Lactoferrin Meta

All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Case 39% Improvement Relative Risk Vitamin D for COVID-19  Cozier et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Prospective study of 1,974 patients in the USA Fewer cases with higher vitamin D levels (p=0.035) Cozier et al., PLoS ONE, July 2021 Favors vitamin D Favors control

Lower serum 25(OH)D levels associated with higher risk of COVID-19 infection in U.S. Black women

Cozier et al., PLoS ONE, doi:10.1371/journal.pone.0255132
Jul 2021  
  Source   PDF   All Studies   Meta AnalysisMeta
Prospective study of vitamin D levels and COVID-19 infection in the Black Women's Health Study, showing higher risk of infection for lower vitamin D levels. Vitamin D levels were from 3-7 years before infection. Levels at the time of infection may differ, which may reduce the size of the effect observed.
This is the 81st of 185 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 115 vigintillion).
risk of case, 38.6% lower, RR 0.61, p = 0.04, high D levels 94 of 1,601 (5.9%), low D levels 33 of 373 (8.8%), NNT 34, adjusted per study, inverted to make RR<1 favor high D levels, odds ratio converted to relative risk, >20ng/mL, multivariable.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Cozier et al., 27 Jul 2021, prospective, USA, peer-reviewed, 6 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
Lower serum 25(OH)D levels associated with higher risk of COVID-19 infection in U.S. Black women
Yvette C Cozier, Nelsy Castro-Webb, Natasha S Hochberg, Lynn Rosenberg, Michelle A Albert, Julie R Palmer
PLOS ONE, doi:10.1371/journal.pone.0255132
Objective Limited evidence suggests that higher levels of serum vitamin D (25(OH)D) protect against SARS-CoV-2 virus (COVID-19) infection. Black women commonly experience 25(OH)D insufficiency and are overrepresented among COVID-19 cases. We conducted a prospective analysis of serum 25(OH)D levels in relation to COVID-19 infection among participants in the Black Women's Health Study. Methods Since 1995, the Black Women's Health Study has followed 59,000 U.S. Black women through biennial mailed or online questionnaires. Over 13,000 study participants provided a blood sample in 2013-2017. 25(OH)D assays were performed in a certified national laboratory shortly after collection of the samples. In 2020, participants who had completed the online version of the 2019 biennial health questionnaire were invited to complete a supplemental online questionnaire assessing their experiences related to the COVID-19 pandemic, including whether they had been tested for COVID-19 infection and the result of the test. We used logistic regression analysis to estimate odds ratios (OR) and 95% confidence intervals (CI) for the association of 25(OH)D level with COVID-19 positivity, adjusting for age, number of people living in the household, neighborhood socioeconomic status, and other potential confounders. Results Among 5,081 eligible participants whose blood sample had been assayed for 25(OH)D, 1,974 reported having had a COVID-19 test in 2020. Relative to women with 25(OH)D levels of 30 ng/mL (75 nmol/l) or more, multivariable-adjusted ORs for COVID-19 infection in
Author Contributions
Alwarawrah, Kiernan, Maciver, Changes in Nutritional Status Impact Immune Cell Metabolism and Function, Front Immunol, doi:10.3389/fimmu.2018.01055
Bailey, Feldman, Bassett, How Structural Racism Works-Racist Policies as a Root Cause of U.S. Racial Health Inequities, N Engl J Med, doi:10.1056/NEJMms2025396
Bertrand, Giovannucci, Liu, Determinants of plasma 25-hydroxyvitamin D and development of prediction models in three US cohorts, Br J Nutr, doi:10.1017/S0007114511007409
Beydoun, Wang, Gender-ethnic disparity in BMI and waist circumference distribution shifts in US adults, Silver Spring), doi:10.1038/oby.2008.492
Bilezikian, Bikle, Hewison, MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19, Eur J Endocrinol, doi:10.1530/EJE-20-0665
Bouillon, Carmeliet, Vitamin D insufficiency: Definition, diagnosis and management, Best Pract Res Clin Endocrinol Metab, doi:10.1016/j.beem.2018.09.014
Burke, Rybicki, Rao, Calcium and vitamin D in sarcoidosis: how to assess and manage, Semin Respir Crit Care Med, doi:10.1055/s-0030-1262215
Colotta, Jansson, Bonelli, Modulation of inflammatory and immune responses by vitamin D, J Autoimmun, doi:10.1016/j.jaut.2017.07.007
Cozier, Albert, Castro-Webb, Neighborhood Socioeconomic Status in Relation to Serum Biomarkers in the Black Women's Health Study, J Urban Health, doi:10.1007/s11524-016-0034-0
Cozier, Berman, Palmer, Boggs, Serlin et al., Sarcoidosis in black women in the United States: data from the Black Women's Health Study, Chest, doi:10.1378/chest.10-0413
Cozier, Palmer, Horton, Fredman, Wise et al., Racial discrimination and the incidence of hypertension in US black women, Ann Epidemiol, doi:10.1016/j.annepidem.2005.11.008
D'avolio, Avataneo, Manca, 25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2, Nutrients, doi:10.3390/nu12051359
Flegal, Carroll, Kit, Ogden, Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010, JAMA, doi:10.1001/jama.2012.39
Flegal, Carroll, Ogden, Curtin, Prevalence and trends in obesity among US adults, 1999-2008, JAMA, doi:10.1001/jama.2009.2014
Getachew, Tizabi, Vitamin D and COVID-19: Role of ACE2, age, gender, and ethnicity, J Med Virol
Glynn, Breadwinning mothers continue to be the U.S. Norm
Gu, Mack, Salvatore, Characteristics Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System, JAMA Netw Open, doi:10.1001/jamanetworkopen.2020.25197
Guan, Ni, Hu, Clinical Characteristics of Coronavirus Disease 2019 in China, N Engl J Med, doi:10.1056/NEJMoa2002032
Hankinson, Manson, Spiegelman, Willett, Longcope et al., Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period, Cancer Epidemiol Biomarkers Prev
Hastie, Mackay, Ho, Vitamin D concentrations and COVID-19 infection in UK Biobank, Diabetes Metab Syndr, doi:10.1016/j.dsx.2020.04.050
Hewison, Vitamin D and the intracrinology of innate immunity, Mol Cell Endocrinol, doi:10.1016/j.mce.2010.02.013
Holick, Environmental factors that influence the cutaneous production of vitamin D, Am J Clin Nutr, doi:10.1093/ajcn/61.3.638S
Holick, Vitamin D deficiency, N Engl J Med, doi:10.1056/NEJMra070553
Holick, Vitamin D for health and in chronic kidney disease, Semin Dial, doi:10.1111/j.1525-139X.2005.18402.x
Holick, Vitamin D status: measurement, interpretation, and clinical application, Ann Epidemiol, doi:10.1016/j.annepidem.2007.12.001
Ilie, Stefanescu, Smith, The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality, Aging Clin Exp Res, doi:10.1007/s40520-020-01570-8
Kalinowski, Taylor, Spruill, Why Are Young Black Women at High Risk for Cardiovascular Disease?, Circulation, doi:10.1161/CIRCULATIONAHA.118.037689
Kaufman, Niles, Kroll, Bi, Holick, SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels, PLoS One, doi:10.1371/journal.pone.0239252
Kotsopoulos, Tworoger, Campos, Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies, Cancer Epidemiol Biomarkers Prev, doi:10.1158/1055-9965.EPI-09-1318
Krishnan, Rosenberg, Djousse, Cupples, Palmer, Overall and central obesity and risk of type 2 diabetes in U.S. black women, Silver Spring)
Looker, Pfeiffer, Lacher, Schleicher, Picciano et al., Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004, Am J Clin Nutr, doi:10.3945/ajcn.2008.26182
Louie, Acosta, Samuel, A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1), Clin Infect Dis, doi:10.1093/cid/ciq152
Lukaszuk, Luebbers, OH)D status: Effect of D3 supplement, Obes Sci Pract, doi:10.1002/osp4.85
Martens, Gysemans, Verstuyf, Mathieu, Vitamin D's Effect on Immune Function, Nutrients, doi:10.3390/nu12051248
Meltzer, Best, Zhang, Vokes, Arora et al., Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results, JAMA Netw Open, doi:10.1001/jamanetworkopen.2020.19722
Oran, Topol, Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review, Ann Intern Med, doi:10.7326/M20-3012
Rosenberg, Adams-Campbell, Palmer, The Black Women's Health Study: a follow-up study for causes and preventions of illness, J Am Med Womens Assoc
Rosner, Fundamentals of biostatistics
Russell, Palmer, Adams-Campbell, Rosenberg, Follow-up of a large cohort of Black women, Am J Epidemiol, doi:10.1093/aje/154.9.845
Sattar, Mcinnes, Mcmurray, Obesity Is a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms, Circulation, doi:10.1161/CIRCULATIONAHA.120.047659
Snowden, Graaf, COVID-19, Social Determinants Past, Present, and Future, and African Americans' Health, J Racial Ethn Health Disparities
Spiegelman, s Faculty Website: Software for Downloading
Van Belle, Gysemans, Mathieu, Vitamin D in autoimmune, infectious and allergic diseases: a vital player?, Best Pract Res Clin Endocrinol Metab, doi:10.1016/j.beem.2011.04.009
Williams, Collins, Racial residential segregation: a fundamental cause of racial disparities in health, Public Health Rep, doi:10.1093/phr/116.5.404
Williams, Race, socioeconomic status, and health. The added effects of racism and discrimination, Ann N Y Acad Sci, doi:10.1111/j.1749-6632.1999.tb08114.x
Zadshir, Tareen, Pan, Norris, Martins, The prevalence of hypovitaminosis D among US adults: data from the NHANES III, Ethn Dis
Zhu, Zhang, Wang, A Novel Coronavirus from Patients with Pneumonia in China, 2019, N Engl J Med, doi:10.1056/NEJMoa2001017
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop